ATXS - Astria Therapeutics Inc

ATXS - Astria Therapeutics Inc

https://www.astriatx.com

Hold Momentum: Bearish

Recent News

Powered by Alpha Vantage

All You Need to Know About Astria Therapeutics ( ATXS ) Rating Upgrade to Buy

Zacks Commentary • 3 days, 23 hours ago • score: 0.38

Astria Therapeutics (ATXS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Astria Therapeutics, Inc. ( ATXS ) Now Trades Above Golden Cross: Time to Buy?

Zacks Commentary • 6 days, 18 hours ago • score: 0.37

Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?

Arm Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Astria Therapeutics ( NASDAQ:ATXS ) , ARM Holdings ( NASDAQ:ARM )

Benzinga • 8 months, 3 weeks ago • score: -0.18

U.S. stock futures were mixed this morning, with the Dow futures falling around 0.2% on Monday. Shares of Arm Holdings plc ARM fell sharply in today's pre-market trading after a US jury reportedly found Qualcomm QCOM did not breach Nuvia's license agreement with the company.

Is Astria Therapeutics ( ATXS ) Stock Outpacing Its Medical Peers This Year?

Zacks Commentary • 8 months, 4 weeks ago • score: 0.43

Here is how Astria Therapeutics, Inc. (ATXS) and Abbott (ABT) have performed compared to their sector so far this year.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

None

52W High

$12.92

52W Low

$3.56

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

0.42

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-7.57

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

2.57

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

0.49%

Institutions (25–75% balanced)

102.55%

Shares Outstanding

56,435,000

Float

34,521,200

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

0

Gross Profit (TTM)

0

EPS (TTM)

-2.02

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-0.39%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

0.3552

Previous

0.3003

Trend

Rising

Signal Cross

No cross

As of

Sep. 11, 2025